Marc Garidel is the founder of Corvidia. Corvidia has raised $86M in total funding. Latest round: Series B. Based in Waltham, MA, USA.
Marc Garidel was appointed Chief Executive Officer of Corvidia Therapeutics Inc. in March 2018. Under his leadership, the company secured a $60 million Series B funding round to accelerate clinical programs and expand its scientific and market access capabilities, focusing on developing precision therapies for complex diseases.
Full founder directory · Investor directory · Company funding database · Fundraising library